Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2435 (LINC02435) is a member of the long intergenic non-coding RNAs (lincRNAs), a subclass of long non-coding RNAs that are transcribed from genomic regions not overlapping with protein-coding genes and are typically longer than 200 nucleotides[1][3][7]. LincRNAs, including LINC02435, are thought to regulate gene expression through a variety of mechanisms such as modulation of chromatin structure, stabilization or destabilization of target RNAs, recruitment or scaffolding of protein complexes, and participating in transcriptional regulation, often exhibiting tissue-specific functions[1][3]. While the general biological properties of lincRNAs are increasingly understood, specific functional and disease associations for LINC02435 are not well characterized in the current literature. LincRNAs’ dysregulation has been linked to diseases, particularly in cancer and developmental contexts, though there is no direct evidence to consider LINC02435 a therapeutic target or druggable receptor/enzyme at this time[1][3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2435 (LINC02435).